Sam Tomy K/ LinkedIn
Jun 5, 2026, 02:29
Sam Tomy K.: Antinuclear Antibody Testing and Its Role in Autoimmune Disease Diagnosis
Sam Tomy K, Laboratory Technician at MVR Cancer Centre and Research Institute, shared a post on LinkedIn:
“Understanding the ANA Test — A Key Marker in Autoimmune Diagnostics
The Antinuclear Antibody (ANA) test plays a crucial role in detecting autoimmune disorders such as lupus, Sjögren syndrome, systemic sclerosis, and mixed connective tissue disease.
In the laboratory, ANA testing by indirect immunofluorescence on HEp-2 cells remains the gold standard for identifying autoantibodies and interpreting fluorescence patterns.
Key highlights:
- ANA patterns and their clinical significance
- HEp-2 cell indirect immunofluorescence
- Titer interpretation
- Common autoimmune associations
- Importance of quality control in ANA testing
As medical laboratory professionals, understanding the science behind ANA testing helps improve diagnostic accuracy and patient care.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 01:48Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026